Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, HIV, Drug Use, Sexual Risk, and Schizophrenia research and treatment.
A mixed‐methods study of staff perspectives on the barriers and facilitators to the implementation of patient‐reported routine outcome measures and feedback in alcohol and other drug treatment
Superiority and cost-effectiveness of Individual Placement and Support versus standard employment support for people with alcohol and drug dependence: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations
Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England
Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records
Measurement‐based care using DSM‐5 for opioid use disorder: can we make opioid medication treatment more effective?
Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis
Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective
DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE
Impact of treatment for opioid dependence on fatal drug‐related poisoning: a national cohort study in England
Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England
“You’re all going to hate the word ‘recovery’ by the end of this”: Service users’ views of measuring addiction recovery
How should we measure addiction recovery? Analysis of service provider perspectives using online Delphi groups
Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT)
Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation
Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite)
Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes
Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction
Risk adjustment of heroin treatment outcomes for comparative performance assessment in <scp>E</scp>ngland